Acquisition Enterprise Partners Pricing 
socalTECH
NOVEMBER 10, 2010
One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Enterprise Partners owns about 14.8 According to a filing from Complete Genomics, it will sell 6 million shares at $9.00
socalTECH
JUNE 30, 2010
According to TargeGen, the deal's purchase price depends on the achievement of certain future milestones events. Tags: targegen sanofi aventis merger acquisition lifescience bioscience. TargeGen's products are also potentially useful in treating certain forms of leukemia, lymphoma, other hematological malignancies and blood disorders.
Expert insights. Personalized for you.
124 
Let's personalize your content